Medical Advocates

HCV Infection/Disease
 
Clinical Variants
 
General Reports
Biliary Disorders

Cirrhosis
Cholestatic Hepatitis
Cytopenia
Fibrosis
Hepatocellular Carcinoma
Insulin Resistance
Liver Stiffness
Metabolic Disorders   

Non-Alcoholic Fatty Liver Disease
Oncological Disorders 
Purpura
Post Transplantation HCV

Renal Disease

Splenic Disease
Statin Hepatotoxicity
Steatosis

End Stage Liver Disease
 

HCV Main Page Main New/Newsworthy    Home Page    

Last Update:  August 11, 2017
 
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General/Miscellaneous Reports
 

 
Efficacy and safety of sofosbuvir-based, interferon-free therapy : The Management of rheumatologic extrahepatic manifestations associated with chronic hepatitis C virus infection.
Shahin AA, Zayed HS, Said M, Amer SA.  
Z Rheumatol
. 2017 Aug 9.
Abstract

Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus-Associated Cryoglobulinemia Treated With Direct-acting Antivirals.
Bonacci M, Lens S, Londoño MC, et al
Clin Gastroenterol Hepatol
. 2016 Oct 7.
Abstract

FULL-TEXt ARTICLE
Generalized Liver- and Blood-Derived CD8+ T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus Infection.
Burke Schinkel SC, Carrasco-Medina L, Cooper CL, Crawley AM.
PLoS One
. 2016 Jun 17;11(6):e0157055.
Paper

FULL-TEXT ARTICLE
Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage.
Valva P, Ríos DA, De Matteo E, Preciado MV.
World J Gastroenterol
. 2016 Jan 28;22(4):1367-81.
Paper

Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy.
Marano M, Vespasiani Gentilucci U et al
Metab Brain Dis
. 2015 Aug 27.
Abstract

Micro-RNA-122 levels in acute liver failure and chronic hepatitis C.
Dubin PH, Yuan H, Devine RK,et al  
J Med Virol. 2014 Jun 4.
Abstract

FULL-TEXT ARTICLE
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.
Zampino R, Marrone A, Restivo L, et al
World J Hepatol
. 2013 Oct 27;5(10):528-540.
Paper

Investigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver disease.
Himoto T, Tani J, Miyoshi H, Morishita A,, et al
Diabetol Metab Syndr
. 2013 Sep 9;5(1):51.
Abstract

Influence of hepatitis C virus on neurocognitive function in patients free from other risk factors: validation from therapeutic outcomes.
Pattullo V, McAndrews MP, Damyanovich A, Heathcote EJ.
Liver Int. 2011 Aug;31(7):1028-38
Abstract

Lymphocytosis as a predictor of poor response to treatment of hepatitis C.
Martinez-Camacho A, Khaoustov VI, Adam E,
Gastroenterol Clin Biol. 2010 Dec 22.
Abstract

Cutaneous sarcoidosis in a woman with chronic hepatitis C and interferon therapy:a case report.
Song K, Das K.
Acta Cytol
. 2010 Sep-Oct;54(5 Suppl):863-6.
Abstract

Biomarkers of fibrosis and impaired liver function in chronic hepatitis C: how well do they predict clinical outcomes?
Peters L, Rockstroh JK.
Curr Opin HIV AIDS
. 2010 Nov;5(6):517-23.
Abstract

Prevalence and Challenges of Liver Diseases in Patients with Chronic Hepatitis C Virus
Infection.
Jacobson IM, Davis GL, El-Serag H, et al
Clin Gastroenterol Hepatol. 2010 Aug 13
Abstract

 


Biliary Disorders
 

  Role of a Short-Term Stent-Trial in a Patient with Biliary Stricture and Portal Hypertensive Biliopathy: Long-Term Outcome Result.
Cantù P, Bezzio C.
Dig Dis Sci. 2010 Aug 19.
Abstract
 

Cholestatic Hepatitis
 

     Journal Papers, Abstracts, and Commentaries
 
 
Early diagnosis and treatment resolved cholestatic hepatitis C without fibrosis after living donor liver transplantation: Report of a case.
Fukuhara T, Morita K, Takeishi K,  et al
Surg Today
. 2010 Oct;40(10):982-985
Abstract

Fatal hepatitis C associated fibrosing cholestatic hepatitis as a complication of cyclophosphamide and corticosteroid treatment of active glomerulonephritis.
Saleh F, Ko HH, Davis JE, Apiratpracha W, et al
Ann Hepatol. 2007 Jul-Sep;6(3):186-9
Abstract

 

Cirrhosis
 

     Journal Papers, Abstracts, and Commentaries
 
 
FULL-TEXT ARTICLE
Antiviral therapies for chronic hepatitis C virus infection with cirrhosis.
Nakamoto S, Kanda T, Shirasawa H, Yokosuka O.
World J Hepatol. 2015 May 18;7(8):1133-41
Paper

Effect of Viral Suppression on Hepatic Venous Pressure Gradient in Hepatitis C With Cirrhosis and Portal Hypertension.
Afdhal N, Everson GT, Calleja JL, et al
J Viral Hepat
. 2017 Mar 10.
Abstract

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of MELD: Analysis of data from the Hepa-C registry.
Fernández Carrillo C, Lens S, Llop E, et al
Hepatology. 2017 Feb 7.
Abstract

ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens.
Coppola N, De Pascalis S, Messina V, et al
Antivir Ther. 2017 Feb 6.
Abstract

Week 4-response predicts sustained virologic response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection.
Pineda JA, Morano-Amado LE, Granados R, et al
Clin Microbiol Infect. 2017 Jan 27. .
Abstract

Evaluation of coagulation during treatment with directly acting antivirals in patients with hepatitis C virus related cirrhosis.
Tripodi A, D'Ambrosio R, Padovan L,
Liver Int. 2017 Jan 2
Abstract

Prognosis of 1169 hepatitis C chronically infected patients with decompensated cirrhosis in the predirect-acting antiviral era.
McDonald SA, Innes HA, Aspinall E,  et a;
J Viral Hepat. 2016 Nov 25.
Abstract

Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis.
Toshikuni N.
Gut Liver
. 2016 Nov 14.
Abstract

Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication.
van der Meer AJ, Feld JJ,  et al
J Hepatol. 2016 Oct 22. .
Abstract

Predictors of hospital re-admissions among Hispanics with hepatitis C-related cirrhosis.
Atla PR, Sheikh MY, Gill F, Kundu R, Choudhury J.
Ann Gastroenterol. 2016 Oct-Dec;29(4):515-520.
Abstract

Th2 Dominance Might Induce Carcinogenesis in Patients with HCV-related Liver Cirrhosis.
Kogame M, Nagai H, Shinohara M, et ak
Anticancer Res
. 2016 Sep;36(9):4529-36.
Abstract

Hepatitis C Virus Infection Is Positively Associated with Gallstones in Liver Cirrhosis.
Zhang FM, Chen LH, Chen HT, et al 
Digestion. 2016 Apr 19;93(3):221-228.
Abstract

Treat chronic hepatitis C virus infection in decompensated cirrhosis - pre- or post-liver transplantation? the ironic conundrum in the era of effective and well-tolerated therapy.
Bunchorntavakul C, Reddy KR.
J Viral Hepat
. 2016 Mar 28..
Abstract

Improvement of renal dysfunction in a patient with HCV-related liver cirrhosis by daclatasvir and asunaprevir combination therapy: A case report.
Tsuge M, Hiramatsu A, Shinohara F, et al
Hepatol Res
. 2015 Nov 27
Abstract

FULL-TEXT ARTICLE
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.
Curry MP, O'Leary JG, Bzowej N,  et al
N Engl J Med
. 2015 Nov 16
Paper

Relationship of hepatic fibrosis, cirrhosis, and mortality with cholecystectomy in patients with hepatitis C virus infection.
Martin DJ, Weideman R, Crook T, Brown G.
Eur J Gastroenterol Hepatol. 2015 Nov 12.
.

Abstract

FULL-TEXT ARTICLE
Direct antiviral agent treatment of decompensated hepatitis C virus-induced liver cirrhosis.

Ohkoshi S, Hirono H, Yamagiwa S.
World J Gastrointest Pharmacol Ther. 2015 Nov 6;6(4):114-9.
Paper

Strategies for treating chronic HCV infection in patients with cirrhosis: latest evidence and clinical outcomes.
Wilder JM, Muir AJ.
Ther Adv Chronic Dis
.
2015 Nov;6(6):314-27
Abstract

Sustained Virologic Response of 100% in HCV Genotype 1b Patients with Cirrhosis Receiving Ombitasvir/Paritaprevir/r and Dasabuvir for 12 Weeks.
Feld JJ, Moreno C, Trinh R, Tam E, et al   
J Hepatol
. 2015 Oct 14.
Abstract

Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy.
Marano M, Vespasiani Gentilucci U et al
Metab Brain Dis
. 2015 Aug 27.
Abstract

Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection.
Yang YH, Chen WC, Tsan YT, et al
Hepatol. 2015 Jul 18. .
Abstract

Antiviral Therapy in Patients with Hepatitis C Virus-Induced Cirrhosis.
Bailly F, Pradat P, Virlogeux V, Zoulim F.
Dig Dis
. 2015;33(4):613-623.
Abstract

Successful and Safe Long-Term Standard Antiviral Therapy in a Patient with "Explosive" Immune Response in Course of HCV-Related Liver Cirrhosis.
Conca P, Cafaro G, De Renzo A, et al
Int J Mol Sci
. 2015 Jun 19;16(6):14075-14085
Abstract

HCV targeting of patients with cirrhosis.
Ferenci P, Kozbial K, Mandorfer M, Hofer H.
J Hepatol
. 2015 Jun 19.
Abstract

Treatment of Hepatitis C in Patients with Cirrhosis: Remaining Challenges for Direct-Acting Antiviral Therapy.
Majumdar A, Kitson MT, Roberts SK.
Drugs
. 2015 May 6.
Abstract

Sorting out cirrhosis: Mechanisms of non-response to hepatitis C therapy.
Al Marzooqi SH, Feld JJ.
Liver Int. 2015 May 2.
Abstract

Management of HCV in Cirrhosis-a Rapidly Evolving Landscape.
Sharma SA, Feld JJ.
Curr Gastroenterol Rep
.
2015 May;17(5):443..
Abstract

Cirrhotic patients are still at risk of developing hepatocellular carcinoma despite Interferon-induced sustained virological response.
Pinzone MR, Zanghì AM, Rapisarda L, et al
Eur Rev Med Pharmacol Sci. 2014 Dec;18(2 Suppl):11-5.
Abstract

Prognostic gene signature profiles of hepatitis C-related early-stage liver cirrhosis.
Venkatesh A, Sun X, Hoshida Y.
Genom Data. 2014 Dec 1;2:361-362.
Abstract

A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration.
King LY, Canasto-Chibuque C, Johnson KB,  et al.
Gut. 2014 Aug 20..
Abstract

HCV cirrhosis at the edge of decompensation: Will ABT-450/r, ombitasvir, dasabuvir and ribavirin solve the need for treatment?
Asselah T, Bruno S, Craxi A.
J Hepatol
. 2014 Aug 19..

Abstract

Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new onset diabetes: A nationwide cohort study.
Huang YW, Yang SS, Fu SC,  et al
Hepatology. 2014 Jun 11..
Abstract

Prevention of Disease Progression with Anti-Inflammatory Therapy in Patients with HCV-Related Cirrhosis: A Markov Model.
Ikeda K, Kawamura Y, Kobayashi M, et al
Oncology. 2014 Jun 7;86(5-6):295-302.
Abstract

ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis.
Poordad F, Hezode C, Trinh R, et al
N Engl J Med. 2014 Apr 11
Abstract

Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens.
Younossi ZM, Stepanova M, Nader F,  et al
Hepatology. 2014 Apr 8.

Abstract

FULL-TEXT ARTICLE
Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation, hepatocarcinogenesis, and mortality.
Toshikuni N, Arisawa T, Tsutsumi M.
World J Gastroenterol. 2014 Mar 21;20(11):2876-2887.
Paper

FULL-TEXT ARTICLE
Skin Adverse Events During Dual and Triple Therapy for HCV-Related Cirrhosis.
Federico A, Sgambato D, Cotticelli G,
Hepat Mon. 2014 Mar 11;14(3):e16632.
Paper

Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study.
Colecchia A, Colli A, Casazza G,  et al
J Hepatol. 2014 Mar 6.
Abstract

Diabetes worsening of hepatitis C cirrhosis: Are alterations in monocytic tissue factor (CD 142) is the cause?
El Makarem MA, Eslam M, Sayed D,  et al
Ann Hepatol. 2013 Jan-2014 Feb;13(1):27-37
Abstract

Treatment of decompensated cirrhosis secondary to hepatitis C with antiviral therapy.
Khokhar N, Qureshi MO, Niazi TK.
J Coll Physicians Surg Pak. 2013 Dec;23(12):833-6..
Abstract

Prediction of liver complications in patients with HCV-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography.
Pérez-Latorre L, Sánchez-Conde M, Rincón D, et al
Clin Infect Dis
. 2013 Nov 21.
Abstract

Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or high-risk esophageal varices among patients with HCV-related cirrhosis.
Morishita N, Hiramatsu N, Oze T, et al
J Gastroenterol. 2013 Sep 5.
Abstract

Splenectomy prior to antiviral therapy in patients with hepatitis C virus related decompensated cirrhosis.
Ji F, Zhang S, Huang N, et al
Braz J Infect Dis. 2013 Jul 2
Abstract

FULL-TEXT ARTICLE
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation.
Ponziani FR, Annicchiarico EB, Siciliano M,  et al
World J Gastroenterol. 2013 Jun 7;
Paper

Oral supplementation with branched-chain amino acid granules prevents hepatocarcinogenesis in patients with hepatitis C-related cirrhosis: a propensity score analysis.
Tada T, Kumada T, Toyoda H,  et al
Hepatol Res. 2013 Mar 29. .
Abstract

How can we treat a patient with liver cirrhosis (hepatitis C virus), hepatocellular carcinoma, and synchronous colon cancer?
Antoniou E, Mantas D, Paraskeva P, et al
Transplant Proc. 2012 Nov;44(9):2745-7.
Abstract

The Natural History of Compensated HCV-Related Cirrhosis; A Prospective Long-Term Study.
Gomez EV, Rodriguez YS, Bertot LC,  et al
J Hepatol. 2012 Oct 27.
Abstract

Efficacy and Anticarcinogenic Activity of Ribavirin Combination Therapy for Hepatitis C Virus-Related Compensated Cirrhosis.
Akuta N, Suzuki F, Seko Y, Kawamura Y,
Intervirology
. 2012 Oct 4.
Abstract

FULL TEXT PDF ARTICLE
Severe Inflammation in the Background Liver Cirrhosis Correlates with the Development of Poorly Differentiated HCC
in HCV-Associated Liver Cirrhosis.
Tarao K, Miyakawa K, Miyagi Y,  et al
Intern Med. 2012;51(18):2495-501. .
Paper

Elevation of the AST to ALT Ratio in Association with the Severity of Esophageal Varices in Patients with HCV-Related Compensated Liver Cirrhosis.
Iwata Y, Enomoto H, Sakai Y, et al
Hepatogastroenterology. 2012 Sep 14;60(121)..

Abstract

Quantifying the fraction of cirrhosis attributable to alcohol among chronic HCV patients: Implications for treatment cost-effectiveness.
nnes HA, Hutchinson SJ, Barclay S,  et al

Hepatology
. 2012 Sep 7.
Abstract

Impact of delayed diagnosis time in estimating progression rates to hepatitis C virus-related cirrhosis
and death.
Fu B, Wang W, Shi X.
Stat Methods Med Res. 2011 Oct 18      
Abstract

Response to standard of care antiviral treatment in patients with HCV liver cirrhosis -
a systematic review.
Bota S, Sporea I, Popescu A, Sirli R

J Gastrointestin Liver Dis
. 2011 Sep;20(3):293-8.
Abstract

Survival rates of early-stage HCV-related liver cirrhosis patients without hepatocellular carcinoma are decreased by alcohol.
Yamada M, Shiroeda H, Hayashi R,  et et al
J Clin Biochem Nutr
. 2011 Mar;48(2):167-9
Abstract


Cytopenia
 

     Journal Papers, Abstracts, and Commentaries
 
Severe autoimmune cytopenias in treatment-naive hepatitis C virus  infection:
clinical description of 35 cases

Ramos-Casals M,Garcia-Carrasco M, Lopez-Medrano F, et al

Medicine
(Baltimore) 2003 Mar;82(2):87-96

Abstract

Insulin Resistance
 

     Journal Papers, Abstracts, and Commentaries
 
Hepatitis C Virus, Insulin Resistance, and Steatosis.
Kralj D, Jukić LV, Stojsavljević S, et al
J Clin Transl Hepatol
. 2016 Mar 28;4(1):66-75

Abstract

Liver Stiffness
 

     Journal Papers, Abstracts, and Commentaries
 
  Improvement of liver stiffness in patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response.
Tada T, Kumada T, Toyoda H, et al
J Gastroenterol Hepatol. 2017 Mar 15.
Abstract

FULL-TEXT ARTICLE
Coffee Intake Is Associated with a Lower Liver Stiffness in Patients with Non-Alcoholic Fatty Liver Disease, Hepatitis C, and Hepatitis B.

Hodge A, Lim S, Goh E, Wong O, et al
Nutrients. 2017 Jan 10;9(1)

Paper

Liver stiffness predicts the response to direct-acting antiviral-based therapy against chronic hepatitis C in cirrhotic patients.
N
eukam K, Morano-Amado LE, Rivero-Juárez A, et al
Eur J Clin Microbiol Infect Dis. 2016 Dec 21

Abstract

FULL-TEXT ARTICLE
Deciding on Interferon-Free Treatment for Chronic Hepatitis C: Updating Liver Stiffness Cut-Off Values to Maximize Benefit.
Colli A, Fraquelli M, Prati D, et al
PLoS One. 2016 Oct 10;11(10):e0164452.

Paper

FULL-TEXT ARTICLE
Liver Stiffness Decreases Rapidly in Response to Successful Hepatitis C Treatment and Then Plateaus.
Chekuri S, Nickerson J, Bichoupan K,
PLoS One. 2016 Jul 21;11(7):e0159413.

Paper

Pioglitazone for Hepatic Steatosis in HIV/Hepatitis C Virus Coinfection.
Matthews L, Kleiner DE, Chairez C, et al
AIDS Res Hum Retroviruses
. 2015 Oct;31(10):961-6

Abstract

FULL-TEXT ARTICLE
Influence of Hepatitis C Virus and IL28B Genotypes on Liver Stiffness.
Lundbo LF, Clausen LN, Weis N, et al 
PLoS One
. 2014 Dec 29;9(12):e115882.

Paper

   
  Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C.
Stasi C, Arena U, Zignego AL, et al
Dig Liver Dis
. 2013 May 6.
Abstract
   
  Liver stiffness is influenced by a standardized meal in patients with chronic hcv hepatitis at different stages of fibrotic evolution.
Arena U, Platon ML, Stasi C, et al
Hepatology
. 2013 Feb 27.
Abstract
   
  A case of MPO-ANCA-positive Wegener's granulomatosis with hepatitis C virus infection
Yasuda M, Araki H, Fujitomo Y,
Nihon Jinzo Gakkai Shi. 2011;53(7):1053-8
Abstract

Non-Alcoholic Fatty Liver Disease
 

     Journal Papers, Abstracts, and Commentaries
 
 
Relation between Body Fat and Liver Fat Accumulation and Cytokine Pattern in Non-Alcoholic Patients with Chronic HCV Infection.
González-Reimers E, Castellano-Higuera A, Alemán-Valls R, et al
Ann Nutr Metab. 2009 Oct 23;55(4):351-357
Abstract

HCV and non-alcoholic fatty liver disease: similar risk factors for necro-inflammation, fibrosis, and cirrhosis.
Comparcola D, Alisi A, Nobili V.
Clin Gastroenterol Hepatol. 2009 Sep 16.
Abstract

 

Purpura
 

     Journal Papers, Abstracts, and Commentaries
 
  Purpura with Cold Urticaria in a Patient with Hepatitis C Virus Infection-Associated Mixed Cryoglobulinemia Type III: Successful Treatment with Interferon-beta.
Ito A, Kazama T, Ito K, Ito M.
IJ Dermatol 2003 Apr;30(4):321-5
Abstract
 

Post-Transplantation HCV
 

 
Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: Lessons on tolerability and efficacy.
Narayanan Menon KV, Poterucha JJ, et al
Liver Transpl 2002 Jul;8(7):623-9
Abstract
 
Update on the Management of Hepatitis C in Liver Transplant Recipients.
A Bobak D, Yadavalli G.
Curr Infect Dis Rep 2002 Apr;4(2):105-111
Abstract
 

Renal Disease/Disorders
 

     Journal Papers, Abstracts, and Commentaries
 
FULL-TEXT ARTICLE
Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case report.
Hasin Y, Shteingart S, Dahari H, et al
World J Hepatol
. 2016 Jul 18;8(20):858-62.
Paper

Treatment of hepatitis C-related kidney disease.
Fabrizi F, Martin P, Cacoub P,  et al
Expert Opin Pharmacother
. 2015 Jul 10:1-13
Abstract

FULL-TEXT ARTICLE
Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection.
Sperl J, Frankova S, Senkerikova R, et al
World J Gastroenterol
. 2015 May 14;21(18):5496-504.
Paper

FULL-TEXT ARTICLE
Hepatitis C Virus Infection Increases Risk of Developing End-Stage Renal Disease Using Competing Risk Analysis.
Lee JJ, Lin MY, Chang JS, Hung CC, et al
PLoS One
. 2014 Jun 27;9(6):e100790.
Paper

Renal involvement in HCV-related vasculitis.
Terrier B, Cacoub P.
Clin Res Hepatol
Gastroenterol
. 2013 Apr 2.
Abstract


Splenic Disease
 

     Journal Papers, Abstracts, and Commentaries

  Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenism.
Akahoshi T, Tomikawa M, Korenaga , et al
Surg Endosc
. 2009 Aug 19|

Abstract

Statin Hepatotoxicity
 

     Journal Papers, Abstracts, and Commentaries

  Incidence of Statin Hepatotoxicity in Patients With Hepatitis C.
Khorashadi S, Hasson NK, Cheung RC. 
Clin Gastroenterol Hepatol. 2006 May 9;

Abstract

Steatosis
 


     Journal Papers, Abstracts, and Commentaries

 
Does steatosis affect the performance of diffusion-weighted MRI values for fibrosis evaluation in patients with chronic hepatitis C genotype 4?
Besheer T, Khaled Razek AA,
Turk J Gastroenterol. 2017 Jun 7
Abstract

The impact of liver steatosis on early and sustained treatment response in chronic hepatitis C patients.
Găman AE, Ungureanu AM, Turculeanu A,  et al
Rom J Morphol Embryol
. 2017;58(1):107-113.
Abstract

Fibrosis in Chronic Hepatitis C: Correlation between Immunohistochemically-Assessed Virus Load with Steatosis and Cellular Iron Content.
Akl M, Hindawi AE, Mosaad M, .et al
Open Access Maced J Med Sci. 2016 Dec 15;4(4):578-584.
Abstract

Hepatitis C Virus, Insulin Resistance, and Steatosis.
Kralj D, Jukić LV, Stojsavljević S, et al
J Clin Transl Hepatol
. 2016 Mar 28;4(1):66-75
Abstract

FULL-TEXT ARTICLE
Steatosis and hepatitis C.

Modaresi Esfeh J, Ansari-Gilani K.
Gastroenterol Rep
(Oxf)
. 2015 Aug 13
Paper

Pioglitazone for Hepatic Steatosis in HIV/HCV Co-infection.
Matthews L, Kleiner D, Chairez C, et al
AIDS Res Hum Retroviruses
. 2015 Jul 27
Abstract

PNPLA3 genetic variants determine hepatic steatosis in non-obese chronic hepatitis C patients.
Huang CF, Chen JJ, Yeh ML, et al
Sci Rep
. 2015 Jul 3;5:11901.
Abstract

FULL-TEXT ARTICLE
Liver steatosis in hepatitis C patients.
González-Reimers E, Quintero-Platt G, Rodríguez-Gaspar M, et al
World J Hepatol. 2015 Jun 8;7(10):1337-46. .
Paper

Exacerbation of Insulin Resistance and Hepatic Steatosis Deriving from Zinc Deficiency in Patients with HCV-Related Chronic Liver Disease.
Himoto T, Nomura T, Tani J  
Biol Trace Elem Res
. 2014 Nov 21
Abstract

FULL-TEXT ARTICLE
Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3.

Abenavoli L, Masarone M, Peta V,  et al
World J Gastroenterol. 2014 Nov 7;20(41):15233-15240
Paper

Hepatitis C virus diversity and hepatic steatosis.
Roingeard P.
J Viral Hepat. 2013 Feb;20(2):77-84.
Abstract

The Association of Genetic Variants with Hepatic Steatosis in Patients with Genotype 1 Chronic Hepatitis C Infection.
Clark PJ, Thompson AJ, Zhu Q,
Dig Dis Sci. 2012 Apr 29.
Abstract

Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis.
Adinolfi LE, Restivo L, Zampino R, et al
Atherosclerosis
. 2012 Feb
Abstract

Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection.
Petta S, Cammà C, Marco VD,  et al
Liver Int. 2011 Apr;31(4):507-15
Abstract

Hepatic steatosis and hepatitis C: Still unhappy bedfellows?
Hwang SJ, Lee SD.
J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:96-101.
Abstract

FULL-TEXT PDF ARTICLE
Steatosis and serum lipid patterns in patients with chronic viral hepatitis: differences related to viral etiology.
Vere CC, Neagoe D, Streba CT,  et al
Rom J Morphol Embryol
. 2010;51(3):509-14
Paper

Hepatitis C virus-induced steatosis: an overview.
Negro F.
Dig Dis
. 2010;28(1):294-9
Abstract
 

Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes.
Mihm S.

Dig Dis
. 2010;28(1):280-4.
Abstract

Hepatic Steatosis in Genotype 4 Chronic Hepatitis C Patients: Implication for Therapy.
Khattab MA, Abdel-Fattah ME, Eslam M,
 et al
J Clin Gastroenterol
. 2010 Feb 25.
Abstract

 

End Stage Liver Disease
 

     Journal Papers, Abstracts, and Commentaries

  Infection With Hepatitis C Virus Genotype 3 is an Independent Risk Factor for End-stage Liver Disease, Hepatocellular Carcinoma, and Liver-related Death.
McMahon BJ, Bruden D, Townshend-Bulson L,  et al
Clin Gastroenterol Hepatol
. 2016 Oct 17.
Abstract


Beyond cure: preventing and managing the complications of end-stage liver disease.
Berenguer M, García-Eliz M, Baiguera C, Puoti M.
Curr Opin HIV AIDS
. 2015 Sep;10(5):355-60
Abstract

Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: modelling the predicted impact of treatment under different scenarios.
Harris RJ, Thomas B, Griffiths J, et al
J Hepatol
. 2014 May 10

Abstract


HCV Main Page Main New/Newsworthy    Home Page    

HCV Clinical Variants